EUVIMED · CrossrefZeitschrift
The Journal of Liquid Biopsy
ISSN 2950-1954 · Elsevier BV
Neueste Artikel
Validation of a ctDNA-Based comprehensive genomic profiling panel (IST80 Plus) for advanced non-small cell lung cancer
Performance evaluation of a novel size-based microfluidic platform for rare cell detection in blood and malignant effusions
Diagnostic threshold optimization of a keratin 17–based urine liquid biopsy assay for urothelial carcinoma detection in patients with hematuria
Is liquid biopsy in oncology cost-effective? A comparative analysis and systematic review
Peritoneal Fluid Reveals a NETosis-associated Cytokine Signature with Diagnostic and Prognostic Value in Advanced High-grade Serous Ovarian Cancer
Development and Validation of a Novel Salivary DNA Methylation Panel for the Early Detection of Oral Cancer
From Molecular Discovery to Clinical Implementation: Longitudinal ctDNA Profiling Defines Molecular Residual Disease and Informs the MONITOR De-escalation Trial
ctDNA as a Dynamic Biomarker to Monitor Immunotherapy Response in KRAS-mutant Non-small Cell Lung Cancer
Episcreen® Liver: Clinical Performance of a cfDNA Methylation Blood Test with AI Integration for Hepatocellular Carcinoma Screening, Surveillance and Treatment Response
Ultra-sensitive Detection of BRAF V600E in Plasma cfDNA of Early-stage Melanoma patients based on PD UV-ME ddPCR
Liquid Biopsy in Potentially Resectable Stage III ALK-Positive NSCLC Treated with Neoadjuvant Alectinib: Results from ALNEO Phase II Trial (GOIRC-01-2020-ML42316)
Signatera Genome™ Assay for Enhanced ctDNA Detection in a Cohort of Patients (pts) with Solid Tumors
Longitudinal Plasma Proteomic Profiling Predicts Immunotherapy Response Dynamics and Overall Survival (OS) in NSCLC
Identifying Educational Needs to Support Personalized Medicine Approaches in Cancer (SPARC): Preliminary Results from the Work Package 6 Survey
Molecular Profiling of Bile-derived DNA: New Perspectives for the Diagnosis and Management of Biliopancreatic Tumors
Transcriptomic Profiling of Circulating Tumour Cells Identifies High-Risk Metastatic Programs and Predicts Recurrence in Oral Squamous Cell Carcinoma
Plasma Immune Mediator Profiling Reveals Distinct Systemic Immune Signatures in High-risk Resected and Advanced Melanoma
Longitudinal Plasma MYCN Monitoring by Digital PCR Enables Early Detection of Molecular Relapse in MYCN-amplified Neuroblastoma
Feasibility of ctDNA-guided Treatment Adaptation in Advanced NSCLC: Preliminary Results from the PALACE Phase II Trial
Feasibility of Extracellular Vesicle and Single-cell Transcriptomic Profiling of Synovial Fluid in Canine Immune-mediated Polyarthritis and Osteoarthritis
Development of A Novel Digital PCR Multiplex Test for Improved Ovarian Cancer Disease Monitoring
Tumor Extracellular Vesicles (TEVs) as a Tool for Investigation of Circulating Tumor and Immune Features in SCLC
Falling at the First Hurdle? A Global External Quality Assessment of cfDNA Extraction Performance
Nanopore cfDNA Multi-omics Liquid Biopsy Monitors Molecular Response in Advanced Lung Adenocarcinoma
HLA and Pharmacogenomics Typing Concordance Between Buffy Coat Sequencing and a Plasma-based Liquid Biopsy Assay
A Plasma-first Framework for Early Molecular Profiling in Suspected Advanced Nsclc: Preliminary Results from the Prospective Multicenter Innova-WP4 Study
Organotropism-Specific CTC Morphology and Heterotypic Clustering Predict Metastatic Site in Solid Tumors
Circulating Tumor DNA (ctDNA) Response to Trastuzumab Deruxtecan (T-Dxd) in Metastatic HER2-positive Breast Cancer
Real-world Implementation of Large Panel ctDNA NGS in Metastatic NSCLC and Colorectal Cancer: Interim Results of the Multicenter LOLA Project
Implementation of a Liquid Biopsy Program for Lung Cancer in Quebec: Generating Real-world Evidence to Support Health Assessment Review
EUVIMED